Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes Article

Goldstein, Steven R, Neven, Patrick, Cummings, Steven et al. (2011). Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes . MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 18(1), 17-22. 10.1097/gme.0b013e3181e84bb4

Industry Collaboration International Collaboration

cited authors

  • Goldstein, Steven R; Neven, Patrick; Cummings, Steven; Colgan, Terence; Runowicz, Carolyn D; Krpan, Dalibor; Proulx, James; Johnson, Margot; Thompson, David; Thompson, John; Sriram, Usha

sustainable development goals

authors

publication date

  • January 1, 2011

webpage

published in

keywords

  • BONE
  • BREAST-CANCER
  • Cancer
  • Endometrial
  • Gynecologic
  • Hyperplasia
  • Lasofoxifene
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • PREVENTION
  • Postmenopausal
  • RALOXIFENE
  • Science & Technology
  • TAMOXIFEN
  • UTERUS
  • WOMEN

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 17

end page

  • 22

volume

  • 18

issue

  • 1